Join Today & Get 4% Cash Back Then 6, 7...Up to 10% Off Reorders!

Online Pharmacy Dictionary

Find drugs by alphabetical list:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z View All

News on Gefitinib (Iressa)

ESMO: IPASS Data Show No Survival Benefit for Gefitinib - MedPage Today

ESMO: IPASS Data Show No Survival Benefit for GefitinibMedPage TodayAlthough preliminary studies did find a significant difference in progression-free survival among patients treated with gefitinib, an epidermal growth ...Erlotinib Trumps Chemo in Advanced NSCLC With EGFR MutationsInternal Medicine News Digital NetworkAstraZeneca's Iressa Drug A Valuable Option - IPASS StudyWall Street JournalErlotinib bested gemcitabine/carboplatin in EGFR-activating advanced NSCLCHemOncTodayMedscape�-News-Medical.net�-TopNews United Kingdomall 79 news articles��

EGFR Mutations Give Survival Benefit in Lung Cancer - Medscape

MedscapeEGFR Mutations Give Survival Benefit in Lung CancerMedscapeHowever, in contrast to earlier findings, overall survival was similar in patients treated with gefitinib and those treated with carboplatin/paclitaxel. ...Afatinib Found to Extend Time to Progression 3-Fold in Advanced NSCLCMedscapeall 2 news articles��

Maintenance Gefitinib Prolongs Progression-Free Survival, but Not Overall ... - DG News

Maintenance Gefitinib Prolongs Progression-Free Survival, but Not Overall ...DG NewsMILAN, Italy -- October 13, 2010 -- Maintenance gefitinib following platinum-based chemotherapy significantly prolongs progression-free ...

Pfizer lung cancer drug looks promising in mid-stage study - FierceBiotech

Pfizer lung cancer drug looks promising in mid-stage studyFierceBiotech... signalling in both wild-type and mutant EGFR, including forms of NSCLC that are resistant to EGFR inhibitors such as erlotinib and gefitinib," Mok adds.and more��

Gefitinib (Iressa)

Last updated on: Jan 24, 2007

What Is Iressa?

Iressa is a medicine used to kill cancer cells (chemotherapy). It is used alone for the continued treatment of patients who are benefiting or have benefited from Iressa. Iressa is approved for patients with non-small cell lung cancer (NSCLC) that:

has progressed after treatment with platinum based and docetaxel chemotherapies, or
did not respond to treatment with platinum based or docetaxel chemotherapies.

What Are The Risks?

The following are the major possible risks and side effects of Iressa therapy. This list is not complete.

Liver damage.
Eye problems, such as pain, redness or change in vision. Some patients have had an injury to the surface of the eye (cornea). This may be caused by eyelashes growing inside the eyelid.
Other side effects with Iressa may include: diarrhea, rash acne, dry skin, nausea, vomiting, itching, loss of appetite, weakness, weight loss

What Should I Tell My Healthcare Professional?

Before being treated with Iressa tell your healthcare professional if you:

have or had liver problems.
are trying to become pregnant, are already pregnant, or are breast-feeding

While being treated with Iressa call your healthcare professional right away if you develop:

severe or continual diarrhea, nausea, vomiting, or loss of appetite. These conditions can lead to low body fluids (dehydration).
an eye problem
any new symptoms

Are There Any Interactions With Drugs or Foods?

Tell your healthcare professional about all the medicines you take, including prescription and over-the-counter drugs, and supplements. Especially tell your health care provider if you take: